Recent progress in emerging molecular targeted therapies for intrahepatic cholangiocarcinoma
肝内胆管癌
医学
癌症研究
内科学
作者
Younghoon Kim,Jaewon Song,Namkyoung Kim,Taebo Sim
出处
期刊:RSC medicinal chemistry [The Royal Society of Chemistry] 日期:2025-01-01
标识
DOI:10.1039/d4md00881b
摘要
Small-molecule and antibody-based targeted therapies for intrahepatic cholangiocarcinoma (iCCA): addressing promising oncogenic molecular alterations, including IDH1, FGFR2, BRAF, HER2, and the PD-1/PD-L1 axis.